Literature DB >> 7295479

Pharmacokinetics of a single evening dose of slow release theophylline in patients with chronic lung disease.

P J Thompson, M A Butcher, L A Frazer, G E Marlin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7295479      PMCID: PMC1401809          DOI: 10.1111/j.1365-2125.1981.tb01248.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  9 in total

1.  The influence of cigarette smoking and sex on theophylline disposition.

Authors:  J R Powell; J F Thiercelin; S Vozeh; L Sansom; S Riegelman
Journal:  Am Rev Respir Dis       Date:  1977-07

2.  On observing patterns of airflow obstruction in chronic asthma.

Authors:  M Turner-Warwick
Journal:  Br J Dis Chest       Date:  1977-04

3.  A comparison of slow-release salbutamol with slow-release aminophylline in nocturnal asthma.

Authors:  J S Milledge; J Morris
Journal:  J Int Med Res       Date:  1979       Impact factor: 1.671

4.  Dose-titration comparison of inhaled salbutamol and oral theophylline in asthma.

Authors:  G E Marlin; M R Harris; J A Klumpp; J Rutland
Journal:  Br J Clin Pharmacol       Date:  1979-12       Impact factor: 4.335

5.  Serum level monitoring of a new slow release theophylline formulation in patients with chronic lung disease.

Authors:  G E Marlin; M A Butcher; J A Klumpp; P J Thompson
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

6.  Theophylline disposition in acutely ill hospitalized patients. The effect of smoking, heart failure, severe airway obstruction, and pneumonia.

Authors:  J R Powell; S Vozeh; P Hopewell; J Costello; L B Sheiner; S Riegelman
Journal:  Am Rev Respir Dis       Date:  1978-08

7.  Theophylline kinetics in acute pulmonary edema.

Authors:  K M Piafsky; D S Sitar; R E Rangno; R I Ogilvie
Journal:  Clin Pharmacol Ther       Date:  1977-03       Impact factor: 6.875

8.  Impaired theophylline clearance in patients with cor pulmonale.

Authors:  N Vicuna; J L McNay; T M Ludden; H Schwertner
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

9.  Slow-release oral salbutamol and aminophylline in nocturnal asthma: relation of overnight changes in lung function and plasma drug levels.

Authors:  A J Fairfax; W R McNabb; H J Davies; S G Spiro
Journal:  Thorax       Date:  1980-07       Impact factor: 9.139

  9 in total
  7 in total

Review 1.  Nonlinear pharmacokinetics: clinical Implications.

Authors:  T M Ludden
Journal:  Clin Pharmacokinet       Date:  1991-06       Impact factor: 6.447

2.  The effect of diet upon serum concentrations of theophylline.

Authors:  P J Thompson; I Skypala; S Dawson; W A McAllister; M Turner Warwick
Journal:  Br J Clin Pharmacol       Date:  1983-09       Impact factor: 4.335

3.  Circadian variation in plasma theophylline concentrations during maintenance therapy with a sustained-release preparation in patients with obstructive airways disease.

Authors:  D R Taylor; D Duffin; C D Kinney; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1984-07       Impact factor: 4.335

4.  Dose-dependent pharmacokinetics with single daily dose slow release theophylline in patients with chronic lung disease.

Authors:  M A Butcher; L A Frazer; H K Reddel; G E Marlin
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

5.  Acute and chronic pharmacokinetics of asymmetrical doses of slow release choline theophyllinate in asthma.

Authors:  S G Hibberd; C Alveyn; E J Coombes; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

6.  Bioavailability and diurnal variation in absorption of sustained release theophylline in asthmatic children.

Authors:  K P Coulthard; D J Birkett; D R Lines; N Grgurinovich; J J Grygiel
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Treatment of children with a single dose a day of sustained release theophylline.

Authors:  S Pedersen
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.